The current stock price of SBC is 3.54 USD. In the past month the price increased by 8.59%. In the past year, price decreased by -42.63%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.33 | 98.53B | ||
| CI | THE CIGNA GROUP | 9.65 | 73.22B | ||
| LH | LABCORP HOLDINGS INC | 16.81 | 22.05B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 117.04 | 21.53B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.7 | 20.31B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.38B | ||
| DVA | DAVITA INC | 12.91 | 8.41B | ||
| HIMS | HIMS & HERS HEALTH INC | 67.24 | 8.27B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 34.45 | 6.34B | ||
| CHE | CHEMED CORP | 19.52 | 6.08B | ||
| RDNT | RADNET INC | 207.37 | 6.08B | ||
| OPCH | OPTION CARE HEALTH INC | 20.58 | 4.87B |
SBC Medical Group Holdings, Inc. engages in management services and products to cosmetic treatment centers. The company is headquartered in Irvine, California and currently employs 863 full-time employees. The company went IPO on 2022-09-26. The firm is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.
SBC MEDICAL GROUP HOLDINGS I
200 Spectrum Center Dr., Suite 300
Irvine CALIFORNIA US
Employees: 863
Phone: 19495930250
SBC Medical Group Holdings, Inc. engages in management services and products to cosmetic treatment centers. The company is headquartered in Irvine, California and currently employs 863 full-time employees. The company went IPO on 2022-09-26. The firm is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.
The current stock price of SBC is 3.54 USD. The price increased by 1.43% in the last trading session.
SBC does not pay a dividend.
SBC has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
SBC stock is listed on the Nasdaq exchange.
5 analysts have analysed SBC and the average price target is 8.33 USD. This implies a price increase of 135.31% is expected in the next year compared to the current price of 3.54.
ChartMill assigns a technical rating of 1 / 10 to SBC. When comparing the yearly performance of all stocks, SBC is a bad performer in the overall market: 88.72% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to SBC. SBC has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months SBC reported a non-GAAP Earnings per Share(EPS) of 0.45. The EPS increased by 39.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 17.71% | ||
| ROA | 10.57% | ||
| ROE | 13.63% | ||
| Debt/Equity | 0.03 |
5 analysts have analysed SBC and the average price target is 8.33 USD. This implies a price increase of 135.31% is expected in the next year compared to the current price of 3.54.
For the next year, analysts expect an EPS growth of -27.17% and a revenue growth -16.5% for SBC